Decoding the Interactions of SM Proteins with SNAREs

por Peng, Ren-Wang
Publicado 2005

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight

por Xu, Duo, Yang, Haitang, Schmid, Ralph A., Peng, Ren-Wang
Publicado 2020

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

por Yang, Haitang, Xu, Duo, Schmid, Ralph A., Peng, Ren-Wang
Publicado 2020

Non-genetic adaptive resistance to KRAS(G12C) inhibition: EMT is not the only culprit

por Ning, Wenjuan, Marti, Thomas M., Dorn, Patrick, Peng, Ren-Wang
Publicado 2022

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness

por Yang, Haitang, Liang, Shun-Qing, Schmid, Ralph A., Peng, Ren-Wang
Publicado 2019

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

por Gao, Yanyun, Kruithof-de Julio, Marianna, Peng, Ren-Wang, Dorn, Patrick
Publicado 2022

A Breakthrough Brought about by Targeting KRAS(G12C): Nonconformity Is Punished

por Ning, Wenjuan, Yang, Zhang, Kocher, Gregor J., Dorn, Patrick, Peng, Ren-Wang
Publicado 2022

Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity

por Yang, Haitang, Yao, Feng, Marti, Thomas M., Schmid, Ralph A., Peng, Ren-Wang
Publicado 2020

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

por Xu, Ke, Ma, Jie, Hall, Sean R. R., Peng, Ren-Wang, Yang, Haitang, Yao, Feng
Publicado 2023

Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT

por Tièche, Colin Charles, Peng, Ren-Wang, Dorn, Patrick, Froment, Laurène, Schmid, Ralph Alexander, Marti, Thomas Michael
Publicado 2016

Schedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells

por Dorn, Patrick, Tièche, Colin Charles, Peng, Ren-Wang, Froment, Laurène, Schmid, Ralph Alexander, Marti, Thomas Michael
Publicado 2016

Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma

por Yang, Haitang, Xu, Duo, Yang, Zhang, Yao, Feng, Zhao, Heng, Schmid, Ralph A., Peng, Ren-Wang
Publicado 2020

Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer

por Yang, Haitang, Zhao, Liang, Gao, Yanyun, Yao, Feng, Marti, Thomas M., Schmid, Ralph A., Peng, Ren-Wang
Publicado 2020

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma

por Karatkevich, Darya, Deng, Haibin, Gao, Yanyun, Flint, Emilio, Peng, Ren-Wang, Schmid, Ralph Alexander, Dorn, Patrick, Marti, Thomas Michael
Publicado 2022

Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses

por Xu, Duo, Liu, Shengchen, Wu, Xi, Marti, Thomas M., Dorn, Patrick, Schmid, Ralph A., Peng, Ren-Wang, Shu, Yongqian
Publicado 2022

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment

por Gao, Yanyun, Dorn, Patrick, Liu, Shengchen, Deng, Haibin, Hall, Sean R. R., Peng, Ren-Wang, Schmid, Ralph A., Marti, Thomas M.
Publicado 2019

NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma

por Yang, Haitang, Hall, Sean R. R., Sun, Beibei, Zhao, Liang, Gao, Yanyun, Schmid, Ralph A., Tan, Swee T., Peng, Ren-Wang, Yao, Feng
Publicado 2021

ACSL3–PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression

por Rossi Sebastiano, Matteo, Pozzato, Chiara, Saliakoura, Maria, Yang, Zhang, Peng, Ren-Wang, Galiè, Mirco, Oberson, Kevin, Simon, Hans-Uwe, Karamitopoulou, Evanthia, Konstantinidou, Georgia
Publicado 2020

HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer

por Yang, Haitang, Liang, Shun-Qing, Xu, Duo, Yang, Zhang, Marti, Thomas M., Gao, Yanyun, Kocher, Gregor J., Zhao, Heng, Schmid, Ralph A., Peng, Ren-Wang
Publicado 2019

Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer

por Yang, Haitang, Sun, Beibei, Xu, Ke, He, Yunfei, Zhang, Tuo, Hall, Sean R R, Tan, Swee T., Schmid, Ralph A., Peng, Ren-Wang, Hu, Guohong, Yao, Feng
Publicado 2021